| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.33B | -4.9% | -10.3% |
| Cost of Revenue | $1.51B | -5.3% | -10.1% |
| R&D Expense | $6.0M | +0.0% | +0.0% |
| SG&A Expense | $256.1M | +6.3% | -6.4% |
| Operating Income | $513.2M | -8.4% | -8.6% |
| Interest Expense | $229.7M | -2.9% | +24.5% |
| Pre-tax Income | $376.1M | -9.3% | -17.0% |
| Income Tax | $92.7M | -7.9% | -18.0% |
| Net Income | $283.4M | -9.8% | -16.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $946.6M | +30.5% | +178.7% |
| Accounts Receivable | $465.2M | -7.0% | -17.7% |
| Inventory | $125.3M | -11.4% | -40.2% |
| Current Assets | $1.84B | +9.2% | -45.1% |
| Total Assets | $8.31B | +2.4% | -14.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.12B | — | — |
| Capital Expenditures | $102.7M | — | — |
| Investing Cash Flow | -$117.6M | — | — |
| Financing Cash Flow | -$508.0M | — | — |
| Free Cash Flow | $1.01B | — | — |
| $5.29B |
| +64.2% |
| +1.4% |
| Long-term Debt | $8.79B | -20.0% | -24.5% |
| Total Liabilities | $14.56B | -0.6% | -16.1% |
| Stockholders' Equity | -$6.25B | +4.4% | +17.7% |